Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumors (2009) Ann Rev Pathol, 4, pp. 97-126
Barhoover, M.A., Hall, J.M., Greenlee, W.F., Thomas, R.S., Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4 (2010) Mol Pharmacol, 77, pp. 195-201
Beckers, A., Higher prevalence of clinically relevant pituitary adenomas confirmed (2010) Clin Endocrinol (Oxf), 72, pp. 290-291
Beischlag, T.V., Morales, J.L., Hollingshead, B.D., Perdew, G.H., The aryl hydrocarbon receptor complex and the control of gene expression (2008) Crit Rev Eukaryot Gene Expr, 18, pp. 207-250
Boikos, S.A., Stratakis, C.A., Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis (2007) Hum Mol Genet, 16, pp. R80-R87. , (Spec No 1)
Cakir, M., Grossman, A.B., Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis (2009) Expert Opin Ther Targets, 13, pp. 1121-1134
Canibano, C., Rodriguez, N.L., Saez, C., Tovar, S., Garcia-Lavandeira, M., Borrello, M.G., Vidal, A., Alvarez, C.V., The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth (2007) EMBO J, 26, pp. 2015-2028
Caronti, B., Paladini, G., Caldelaro, C., Bevilacqua, M.G., Petrangeli, E., Esposito, V., Tamburrano, G., Jaffrain-Rea, M.L., Effects of gonadal steroids on the growth of human pituitary adenomas in vitro (1995) Tumor Biol, 16, pp. 353-364
Carver, L.A., La Pres, J.J., Jain, S., Dunham, E.E., Bradfield, C.A., Characterization of the Ah receptor - associated protein ARA9 (1998) J Biol Chem, 50, pp. 33580-33587
Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., Borson-Chazot, C., Beckers, A., Clinical characterization of familial isolated pituitary adenomas (2006) J Clin Endocrinol Metab, 91, pp. 3316-3323
Daly, A.F., Vanbellinghen, J.F., Khoo, S.K., Jaffrain-Rea, M.L., Naves, L.A., Guitelman, M.A., Murat, A., Beckers, A., Arylhydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: Analysis in 73 families (2007) J Clin Endocrinol Metab, 92, pp. 1891-1896
Daly, A.F., Tichomirowa, M.A., Petrossians, P., Heliovaara, E., Jaffrain-Rea, M.L., Barlier, A., Naves, L.A., Beckers, A., Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study (2010) J Clin Endocrinol Metab, 95, pp. E373-E383
De Oüveira, S.K., Smolenski, A., Phosphodiesterases Link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling (2009) Biochem Pharmacol, 77, pp. 723-733
Elango, A., Shepherd, B., Chen, T.T., Effects of endocrine disrupters on the expression of growth hormone and prolactin mRNA in the rainbow trout pituitary (2006) Gen Comp Endocrinol, 145, pp. 116-127
Galdelha, M.R., Prezant, T.R., Une, K.R., Glick, R.P., Moskal Ii, S.F., Vaisman, M., Melmed, S., Frohman, L.A., Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene (1999) J Clin Endocrinol Metab, 84, pp. 249-256
Heliovaara, E., Raitila, A., Launonen, V., Paetau, A., Arola, J., Lehtonen, H., Sane, T., Karhu, A., The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas (2009) Am J Pathol, 175, pp. 2501-2507
Henklovà, P., Vrzal, R., Ulrichovà, J., Dvorak, Z., Role of mitogen-activated protein kinases in aryl hydrocarbon signaling (2008) Chem Biol Interact, 172, pp. 93-104
Igreja, S., Chahal, H.S., King, P., Bolger, G.B., Srirangalingam, U., Guasti, L., Chapple, J.P., Korbonits, M., Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families (2010) Hum Mut, 31, pp. 950-960
Jaffrain-Rea, M.L., Petrangeli, E., Ortolani, F., Fraioli, B., Lise, A., Esposito, V., Spagnoli, L.G., Gulino, A., Cellular receptors for sex steroids in human pituitary adenomas (1996) J Endocrinol, 151, pp. 175-184
Jaffrain-Rea, M.L., Angelini, M., Gargano, D., Tichomirowa, M.A., Daly, A.F., Vanbellinghen, J.F., D’Innocenzo, E., Beckers, A., Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: Pathological and clinical implications (2009) Endocr Relat Cancer, 16, pp. 1029-1043
Jaffrain-Rea, M.L., Daly, A.F., Angelini, M., Petrossians, P., Bours, V., Beckers, A., Genetic susceptibility in pituitary adenomas: From pathogenesis to clinical implications (2010) Exp Rev Endocrinol Metab, 6 (2), pp. 195-214
Jaffrain-Rea, M.L., Angelini, M., Tichomirowa, M.A., Theodoropoulou, M., Daly, A.F., Barlier, A., Naves, L.A., Beckers, A., Factors associated with AIP expression in somatotropinomas and the possible influence of somatostatin analogues (2010) 15Th Congress of the European Neuroendocrine Association, pp. 22-25. , Liège, September 2010, Belgium
Japón, M.A., Urbano, A.G., Sáez, C., Segura, D.I., Cerro, A.L., Diéguez, C., Alvarez, C., Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors (2002) J Clin Endocrinol Metab, 87, pp. 1879-1884
Laenger, A., Lang-Rollin, I., Kozany, C., Zschocke, J., Zimmermann, N., Rüegg, J., Holsboer, F., Rein, T., XAP2 inhibits glucocorticoid activity in mammalian cells (2009) FEBS Let, 583, pp. 1493-1498
Leontiou, C.A., Gueorguiev, M., Van Der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H.S., Korbonits, M., The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas (2008) J Clin Endocrinol Metab, 93, pp. 2390-2401
Lin, B.C., Sullivan, R., Lee, Y., Moran, S., Glover, E., Bradfield, C.A., Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality (2007) J Biol Chem, 282, pp. 35924-35932
Marlowe, J.L., Puga, A., Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis (2005) J Cell Biochem, 96, pp. 1174-1184
Ozfirat, Z., Korbonits, M., AIP gene and familial isolated pituitary adenomas (2010) Mol Cell Endocrinol, 326, pp. 71-79
Puga, A., Ma, C., Marlowe, J.L., The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways (2009) Biochem Pharmacol, 77, pp. 713-722
Raitila, A., Lehtonen, H.J., Arola, J., Heliovaara, E., Ahlsten, M., Georgitsi, M., Jalanko, A., Karhu, A., Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression (2010) Am J Pathol, 177, pp. 1969-1976
Sumanasekera, W.K., Tien, E.S., Turpey, R., Van Den Heuvel, J.P., Perdew, G.H., Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2 (2003) J Biol Chem, 278, pp. 4467-4473
Thakker, R.V., Multiple endocrine neoplasia type 1 (MEN1) (2010) Best Pract Res Clin Endocrinol Metab, 24, pp. 355-370
Toledo, R.A., Mendonca, B.B., Fragoso, M.C., Soares, I.C., Almeida, M.Q., Moraes, M.B., Lourenço-Jr, D.M., Toledo, S.P., Isolated familial somatotropinoma:11q13-OHand gene/proteinexpression analysis suggests a possible involvement of AIP also in non-pituitary tumorigenesis (2010) Clinics (Sao Paulo), 65, pp. 407-415
Tolon, R.M., Castillo, A.I., Aranda, A., Activation of the prolactin gene by peroxisome proliferator-activated receptor a appears to be DNA binding-independent (1998) J Biol Chem, 41, pp. 26652-26661
Vargiolu, M., Fusco, D., Kurelac, I., Dirnberger, D., Baumeister, R., Morra, I., Melcarne, A., Bonora, E., The tyrosine kinase receptor RET interacts in vivo with arylhydrocarbon receptor-interacting protein to alter survivin availability (2009) J Clin Endocrinol Metab, 94, pp. 2571-2578
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Aaltonen, L.A., Pituitary adenoma predisposition caused by germline mutations in the AIP gene (2006) Science, 312, pp. 1228-1230
